这是附加信息
Description
CJC-1295 with DAC is a synthetic modified peptide compound engineered for laboratory research. The molecule features a Drug Affinity Complex (DAC) modification that enhances its stability in experimental conditions. Laboratory research demonstrates specific molecular pathway interactions and distinct binding properties in controlled models. The compound is designed with a 30-amino acid sequence structure, showing selective receptor affinity in vitro studies. The DAC modification allows for extended stability in solution compared to the non-modified variant, making it particularly suitable for prolonged laboratory studies.
Dual-Pathway Secretagogue Synergy: "Expertly blended to study the synergistic effects of GHRH and GHRP analogs on pulsatile signaling pathways."
Circadian Rhythm Alignment: "The 'No DAC' formulation is specifically designed for research into natural circadian rhythms and nocturnal metabolic peaks."
99%+ High-Fidelity Synthesis: "Individually HPLC-verified components blended in a 1:1 ratio to ensure maximum experimental reliability."
Properties
Components: Peptide C (No DAC) + Peptide I (Ipamorelin)
Ratio: 5mg : 5mg Precision Blend
Purity: ≥ 99.2% (HPLC Verified)
Research Focus: Sleep-cycle optimization, lean tissue homeostasis, and cellular repair signaling
You have successfully commented, please wait for review
Copied Successfully
You can enjoy up to 1 free gift!